Initializing potency table...
Ligand source activities (1 row/activity)
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
1,10-Phenanthroline | 6 | None | 76 | Human | Binding | IC50 | = | 74000.00 | 4.13 | - | 5 | Displacement of [125I]-CCL3 from human CCR1 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs | ChEMBL | 180.1 | 0 | 0 | 2 | 2.78 | c1cnc2c(c1)ccc1cccnc12 | https://dx.doi.org/10.1021/jm301121j | |
1,10-Phenanthroline | 6 | None | 76 | Human | Binding | IC50 | = | 79432.82 | 4.10 | - | 5 | Displacement of [125I]-CCL3 from human CCR1 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs | ChEMBL | 180.1 | 0 | 0 | 2 | 2.78 | c1cnc2c(c1)ccc1cccnc12 | https://dx.doi.org/10.1021/jm301121j | |
AZD4818 | 82599 | None | 0 | Human | Binding | Ki | = | 5.00 | 8.30 | - | 1 | Binding affinity to CCR1 | ChEMBL | 461.2 | 9 | 4 | 6 | 3.39 | CC(=O)Nc1ccc(O)cc1OC[C@@](C)(O)CNC1CCN(Cc2ccc(Cl)cc2)CC1 | https://dx.doi.org/10.1021/jm300682j | |
banyu (I) | 574 | None | 5 | Human | Binding | IC50 | = | 1900.00 | 5.72 | - | 2 | Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR1 receptor expressed in CHO cells | ChEMBL | 480.1 | 6 | 2 | 6 | 5.06 | Nc1ccc2nc(SCC(=O)NC3CCN(Cc4ccc(Cl)c(Cl)c4)CC3)sc2c1 | https://dx.doi.org/10.1016/s0960-894x(01)00176-7 | |
BERLEX COMPOUND | 118652 | None | 11 | Human | Binding | Ki | = | 52.00 | 7.28 | - | 4 | Inhibition of [125I]-MIP-1 alpha binding to recombinant human C-C chemokine receptor type 1 expressed in HEK293 cells | ChEMBL | 444.2 | 7 | 1 | 3 | 5.91 | N#CC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 | https://dx.doi.org/10.1021/jm990316l | |
BERLEX COMPOUND | 118652 | None | 11 | Human | Binding | IC50 | = | 48.00 | 7.32 | - | 4 | Inhibitory activity against [125I]-MIP-1 alpha binding to human CCR1 receptors. | ChEMBL | 444.2 | 7 | 1 | 3 | 5.91 | N#CC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 | https://dx.doi.org/10.1021/jm0004244 | |
BERLEX COMPOUND | 118652 | None | 11 | Human | Binding | IC50 | = | 630.00 | 6.20 | - | 4 | Inhibitory activity against human Chemokine receptor type 1 expressed in chinese hamster ovary cells | ChEMBL | 444.2 | 7 | 1 | 3 | 5.91 | N#CC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 | https://dx.doi.org/10.1021/jm0201767 | |
BERLEX COMPOUND | 118652 | None | 11 | Mouse | Binding | IC50 | = | 5000.00 | 5.30 | - | 4 | Inhibitory activity against [125I]-MIP-1 alpha binding to mouse CCR1 receptors. | ChEMBL | 444.2 | 7 | 1 | 3 | 5.91 | N#CC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 | https://dx.doi.org/10.1021/jm0004244 | |
BI 639667 | 171085 | None | 20 | Human | Binding | IC50 | = | 2.00 | 8.70 | - | 2 | Antagonist activity at CCR1 in human THP1 cells assessed as inhibition of chemotaxis after 30 mins by Celltiter-glo reagent based luminescence assay | ChEMBL | 451.1 | 5 | 1 | 7 | 2.78 | CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1 | https://dx.doi.org/10.1016/j.bmcl.2018.12.024 | |
BI 639667 | 171085 | None | 20 | Human | Binding | IC50 | = | 5.40 | 8.27 | - | 2 | Scintillation Proximity Assay binding | ChEMBL | 451.1 | 5 | 1 | 7 | 2.78 | CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1 | https://dx.doi.org/10.6019/CHEMBL4507278 | |
BI 639667 | 171085 | None | 20 | Human | Binding | IC50 | = | 24.00 | 7.62 | - | 2 | Ca flux | ChEMBL | 451.1 | 5 | 1 | 7 | 2.78 | CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1 | https://dx.doi.org/10.6019/CHEMBL4507278 | |
BI 639667 | 171085 | None | 20 | Human | Binding | IC50 | = | 2.40 | 8.62 | - | 2 | Chemotaxis | ChEMBL | 451.1 | 5 | 1 | 7 | 2.78 | CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1 | https://dx.doi.org/10.6019/CHEMBL4507278 | |
BI 639667 | 171085 | None | 20 | Human | Binding | IC50 | = | 2.40 | 8.62 | - | 2 | Affinity On-target Cellular interaction (Chemotaxis in THP-1 cells) EUB0000352a CCR1 | ChEMBL | 451.1 | 5 | 1 | 7 | 2.78 | CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1 | https://dx.doi.org/10.6019/CHEMBL5210121 | |
BI 639667 | 171085 | None | 20 | Human | Binding | IC50 | = | 9.00 | 8.05 | - | 2 | Receptor internalization | ChEMBL | 451.1 | 5 | 1 | 7 | 2.78 | CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1 | https://dx.doi.org/10.6019/CHEMBL4507278 | |
BI 639667 | 171085 | None | 20 | Human | Binding | IC50 | = | 5.40 | 8.27 | - | 2 | Affinity Biochemical interaction (Scintillation Proximity Assay (SPA)) EUB0000352a CCR1 | ChEMBL | 451.1 | 5 | 1 | 7 | 2.78 | CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1 | https://dx.doi.org/10.6019/CHEMBL5210307 | |
BMS-817399 | 675 | None | 16 | Human | Binding | IC50 | = | 1.50 | 8.82 | - | 2 | Antagonist activity at CCR1 in human THP1 cells assessed as inhibition of chemotaxis after 30 mins by Celltiter-glo reagent based luminescence assay | ChEMBL | 438.2 | 6 | 3 | 4 | 3.09 | CC(C)[C@@H](NC(=O)CC(C)(C)O)C(=O)N1CC[C@](O)(c2ccc(Cl)cc2)C(C)(C)C1 | https://dx.doi.org/10.1016/j.bmcl.2018.11.015 | |
BMS-817399 | 675 | None | 16 | Human | Binding | Ki | = | 3.70 | 8.43 | - | 2 | Binding Assay: For radioligand competition studies, a final concentration of 1x105 THP-1 monocytic leukemia cells are combined with 100 μg of LS WGA PS beads (Amersham, Cat.#: RPNQ 0260) in 40 μL of assay buffer (RPMI 1640 without phenol red, 50 mM HEPES, 5 mM MgCl2, 1 mM CaCl2, 0.1% BSA). The THP-1 cell/bead mixture was added to each well of a 384-well assay plate (PerkinElmer, Cat. #:6007899) containing test compound in 3-fold serial dilution, with final concentrations ranging from 8 μM to 0.14 nM. A final concentration of 0.1 nM [125I]-MIP-1α (PerkinElmer, Cat. #NEX298) in 20 μL assay buffer was added to the reaction. Unlabeled MIP-1α was added in excess to some wells to determine non-specific binding. Sealed assay plates were incubated at room temperature for 12 h then analyzed by LEADseeker. | ChEMBL | 438.2 | 6 | 3 | 4 | 3.09 | CC(C)[C@@H](NC(=O)CC(C)(C)O)C(=O)N1CC[C@](O)(c2ccc(Cl)cc2)C(C)(C)C1 | - | |
BMS-817399 | 675 | None | 16 | Human | Binding | IC50 | = | 42.00 | 7.38 | - | 2 | Antagonist activity at CCR1 receptor in human whole blood assessed as blocked of LKN1-mediated CD11b upregulation preincubated for 1 hr | ChEMBL | 438.2 | 6 | 3 | 4 | 3.09 | CC(C)[C@@H](NC(=O)CC(C)(C)O)C(=O)N1CC[C@](O)(c2ccc(Cl)cc2)C(C)(C)C1 | https://dx.doi.org/10.1021/jm5003167 | |
BMS-817399 | 675 | None | 16 | Human | Binding | IC50 | = | 25.00 | 7.60 | - | 2 | Antagonist activity at CCR1 receptor in human whole blood assessed as blocked of MIP-1alpha-mediated CD11b upregulation preincubated for 1 hr | ChEMBL | 438.2 | 6 | 3 | 4 | 3.09 | CC(C)[C@@H](NC(=O)CC(C)(C)O)C(=O)N1CC[C@](O)(c2ccc(Cl)cc2)C(C)(C)C1 | https://dx.doi.org/10.1021/jm5003167 | |
BMS-817399 | 675 | None | 16 | Human | Binding | IC50 | = | 14.30 | 7.84 | - | 2 | Antagonist activity at CCR1 receptor in human THP1 cells assessed as inhibition of MPIF1-induced chemotaxis after 60 mins | ChEMBL | 438.2 | 6 | 3 | 4 | 3.09 | CC(C)[C@@H](NC(=O)CC(C)(C)O)C(=O)N1CC[C@](O)(c2ccc(Cl)cc2)C(C)(C)C1 | https://dx.doi.org/10.1021/jm5003167 |
Showing 1 to 20 of 917 entries
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name |
GPCRdb ID |
Reference ligand |
Vendors | Species | Assay Type |
Activity Type |
Activity Relation |
Activity Value |
p-value (-log) |
Fold selectivity |
Tested GPCRs |
Assay Description |
Source | Mol weight |
Rot Bonds |
H don | H acc | LogP | Smiles | DOI | |